Regulus Therapeutics Inc. is covered by the following analysts.

Firm Analyst
Cantor Fitzgerald
Brian Cheng
H.C. Wainwright
Raghuram Selvaraju, Ph.D.
Needham & Company
L. Alan Carr, Jr., Ph.D., CFA
Liana Moussatos
Wells Fargo Securities
Yanan Zhu, Ph.D.

Regulus Therapeutics Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Regulus Therapeutics Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Regulus Therapeutics Inc. or its management. Regulus Therapeutics Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.